Company Filing History:
41 out of 2,285 
2 out of 228 
1 out of 4 Years Active: 2001-2017
Areas of Expertise:
Title: Innovations by Wenkui Ken Fang: A Pioneer in α-Adrenergic Modulation
Introduction
Wenkui Ken Fang, based in Irvine, CA, is an accomplished inventor with a significant portfolio of 44 patents. His work primarily focuses on innovative methods for treating α-adrenergic mediated conditions, showcasing his commitment to advancing medical science and improving patient care.
Latest Patents
Among his latest patents are groundbreaking methods for treating α-adrenergic mediated conditions, which describe compounds and methods for addressing various diseases in subjects. These patents detail the administration of pharmaceutical compositions containing effective amounts of α-adrenergic modulators. Remarkably, Fang's inventions also encompass therapies that alleviate acute, neuropathic, and chronic pain, demonstrating his expansive reach into multifaceted health solutions.
Career Highlights
Throughout his career, Wenkui Ken Fang has been associated with prominent companies like Allergan, Inc. and Allergan Sales, Inc., where he played a pivotal role in research and development initiatives that have contributed to significant advancements in pharmaceuticals.
Collaborations
Fang's innovative work has also involved collaboration with talented professionals such as Ken Chow and Evelyn G. Corpuz. These collaborations highlight the importance of teamwork in achieving remarkable breakthroughs in the field of medicine and innovation.
Conclusion
Wenkui Ken Fang stands out as a leading inventor in the realm of α-adrenergic mediated treatments. With his extensive patent portfolio and collaborative approach, he continues to make invaluable contributions to the field of pharmacology, ultimately benefiting countless patients.